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FEBS Letters is intended to be a journal for the fast dissemination of significant and novel work in an essentially complete 
form. It is NOT the vehicle for preliminary or fragmentary observations, or for ‘leftovers’ from larger papers, or for 
material which, although sound, does not have to appear quickly, or is addressed to a small audience only. As a rule, for 
example, we do not publish incomplete sequences, or sequences which are known in other species; or incomplete NMR or 
other spectroscopic assignments; or the conventionally achieved expression of a gene in bacteria or yeast; or just negative 
observations. Also, methodological papers are not usually published by us, unless they are truly novel and significant. The 
overriding criterion is that a paper must be of sufficient immediate importance to justify urgent publication. As space is 
finite, we are forced to refuse papers which, although sound, do not have top priority. We apologise, therefore, for 
‘approving but not publishing’ such manuscripts. 
Attention of the authors is drawn to the fact that our rejection procedure may take as long as in other journals, as 
explained elsewhere (see FEBS Letters, 217 (1987) 143-144. For details on the preparation of tlie manuscripts, see our 
‘Notes’ (e.g. FEBS Letters, Volume 340, No. 3, pp. 295-296 and thereafter at the end of each tenth volume, i.e. at the end 
of Vol. 350,360,370, etc.). 
The authors should submit their papers to the Editor who is the closest to their field of interest (rather than geographical- 
ly): this accelerates the reviewing process. In case of doubt, please contact any editor. The ‘date of receipt’ eventually 
appearing in the published paper will be that upon which the editor who actually handled the manuscript took receipt of it. 
The authors must submit, if at all possible, a floppy disk of their manuscript (see under Notes to Authors). This accelerates 
the handling process and reduces the danger of misprints eventually appearing. 
oft: t&&x numbers are included below (in parentheses). *When corresponding with these editors it is preferable to use a courier service 
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